Anderon finalizes agreement for $1 billion CHIPS award
Anderon, an IBM company, operates a state-of-the-art 300-millimeter pure-play quantum wafer foundry, backed by an additional USD 1 billion investment from IBM. Headquartered in New York, the new venture serves the quantum industry as a pure-play foundry.
Anderon, an IBM company, has announced the finalization of a USD 1 billion award under the CHIPS and Science Act with the U.S. Department of Commerce. The award will accelerate Anderon’s R&D efforts to advance the nation’s quantum wafer manufacturing capabilities, IBM said.
Anderon operates a state-of-the-art 300-millimeter pure-play quantum wafer foundry, backed by an additional USD 1 billion investment from IBM. Headquartered in Albany, New York, the new venture serves the quantum industry as a pure-play foundry, offering quantum wafer manufacturing to customers across the ecosystem.
“This agreement with the Department of Commerce strengthens our ability to deliver the manufacturing scale the quantum industry needs,” said Mukesh Khare, CEO, Anderon. “We’re building a foundation that will let quantum move from research breakthroughs to real-world impact.”
“IBM’s quantum roadmap requires a manufacturing foundation that can scale at the pace our work demands,” said Jay Gambetta, Director, IBM Research & IBM Fellow. “Anderon’s focus on wafer fabrication gives us exactly that and strengthens our ability to execute and accelerate progress toward the next era of quantum computing.”
Anderon offers specialized wafers supporting high-performance superconducting qubit arrays, quantum input/output signaling, and readout signal chain components, foundational capabilities that support a range of quantum architectures. It plans to expand to other quantum modalities in the future.
